arrow
BackJournal Details
J

Journal of Clinical Pharmacology

IF2.3
Papers106
Citations7626
Journal Papers 108
Publication Date
First-in-Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle-Specific Kinase Agonist Adimanebart (ARGX-119)
delete2026-05-19
delete0
deleteOAAI
deletevan Bragt, Tonke; Kneip, Christa; Priem, Sofie; Leng, Xinghong; Mutch, Rachelle; Patel, Sonya K.; Vanhoenacker, Peter; Vaghi, Cristina; Hoefman, Sven; Shilling, Rebecca; Vanhauwaert, Roeland
deleteShare
deleteSave
Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models
delete2026-05-19
delete0
deleteOAAI
deleteGaffney, Anna; Franchetti, Yoko; Desrosiers, Mathieu; Trame, Mirjam N.; Jewell, Roxanne C.
deleteShare
deleteSave
Reframing Non-Traditional PharmD Career Opportunities Across Drug Development, Regulatory, and Academia
delete2026-05-16
delete0
PREAI
deleteNome, Michael; Kim, Myong Jin; Burnham, Janelle; Nolin, Thomas D.; Prokopienko, Alexander J.
deleteShare
deleteSave
Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults
delete2026-05-15
delete0
deleteOAAI
deleteIlsley, Emma; Banham-Hall, Edward; Chaychenko, Tetyana; Chinenyeze, Katerina; Maher-Edwards, Gareth; Muya, Catherine; Rolfe, Katie; Sharma, Raman; Tiberi, Simon; Barros-Aguirre, David
deleteShare
deleteSave
Pharmacokinetics, Safety, and Tolerability of Anti-miR-17 Oligonucleotide RGLS4326 in Healthy Adult Subjects
delete2026-05-14
delete0
PREAI
deleteOwen, Tate; Cole, Izaiah; Drygin, Denis; Valencia, Tania; Lee, Edmund C.; Carlson, Morgan; Ruff, Laura; Padgett, Claire; Cremer, Karl; Wright, Timothy M.; Garg, Rekha; Klassen, Preston; Kamel, Amin
deleteShare
deleteSave
A Phase 1 Oral Mass Balance and Combined Intravenous [14C] Microtracer Study to Characterize the Absorption, Metabolism, Excretion, and Pharmacokinetics of Antitumor Drug E7386 in Humans
delete2026-05-14
delete0
deleteOAAI
deletePathak, Shriram M.; Hayata, Nozomi; Ueno, Takashi; Aluri, Jagadeesh; Wu, Jincao; Brooks, Ashley S.; Laing, Catherine M.; Dutta, Lea; Yasuda, Sanae
deleteShare
deleteSave
Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population
delete2026-05-05
delete0
deleteOAAI
deleteHelfer, Victoria Etges; Medina-Aymerich, Lorena; Muller, William J.; Meyer, Marisa; Al-Uzri, Amira; McCulloh, Russell; Hornik, Chi D.; Balevic, Stephen J.; Greenberg, Rachel G.; Benjamin, Daniel K.; Anderson, Sarah G.; Gonzalez, Daniel
deleteShare
deleteSave
Limitations of Subgroup Safety Analyses for Drug-Drug Interaction Evaluation: Insights from the Talazoparib P-gp Inhibitor Case
delete2026-04-30
delete0
deleteOAAI
deleteWang, Diane; Nanavati, Charvi; Yang, Derek Z.; DeAnnuntis, Liza; Elmeliegy, Mohamed
deleteShare
deleteSave
The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia
delete2026-04-29
delete1
deleteOAAI
deleteNagy, Peter; Fowler, Justin Corey; Rosenbrock, Holger; Tang, Wenbo; Fu, Eric; Fraser, Annie; Dursema, Holly; Schlichtiger, Julia; Desch, Michael; Gruenenfelder, Fredrik
deleteShare
deleteSave
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes
delete2026-04-29
delete0
deleteOAAI
deleteZhou, Xiao-Jian; Vo, Alex; Morelli, Gaetano; Montrond, Maureen; Lynch, Shannan; Pietropaolo, Keith; Belanger, Bruce; Good, Steven; Horga, Arantxa; Agrawal, Nancy; Hammond, Janet
deleteShare
deleteSave
Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir
delete2026-04-29
delete0
deleteOAAI
deleteNiu, Jing; Zhang, Haeyoung; Ling, John; Madera, Sharline; Kwok, Nerissa; West, Steve; Longo, Diane; Gillespie, Gillian; Llamoso, Cyril; Marathe, Dhananjay D.
deleteShare
deleteSave
Assessment of the Drug-Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol
delete2026-04-29
delete0
deleteOAAI
deleteCronenberger, Carol; Amin, Neeta B.; Le, Vu H.; Carvajal-Gonzalez, Santos; Ashworth, Amy L.; Yi, Ellen C.; Schuster, Tilman; Zhang, Yizhong; Frederich, Robert C.; Friedman, Gary S.; Wang, Ellen Q.; Tsamandouras, Nikolaos
deleteShare
deleteSave
A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End-Stage Kidney Disease on Hemodialysis
delete2026-04-24
delete1
deleteOAAI
deleteMohrmann, Caroline; Oberoi, Rajneet K.; Flach, Stephen D.; Marbury, Thomas C.; Hernandez, Pedro; Gokhale, Manoj; MacElrevey, Celeste R.; Sampson, Caitlin; Amouzadeh, Hamid; Hudson, Krischan; Upreti, Vijay V.; Ward, Jessica A.
deleteShare
deleteSave